Zbigniew Puch

659 total citations
20 papers, 362 citations indexed

About

Zbigniew Puch is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, Zbigniew Puch has authored 20 papers receiving a total of 362 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Surgery and 5 papers in Genetics. Recurrent topics in Zbigniew Puch's work include Thyroid Cancer Diagnosis and Treatment (19 papers), Thyroid and Parathyroid Surgery (5 papers) and Thyroid Disorders and Treatments (4 papers). Zbigniew Puch is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (19 papers), Thyroid and Parathyroid Surgery (5 papers) and Thyroid Disorders and Treatments (4 papers). Zbigniew Puch collaborates with scholars based in Poland and United States. Zbigniew Puch's co-authors include Barbara Jarząb, Józef Roskosz, Daria Handkiewicz-Junak, Aleksandra Kukulska, Jan Włoch, Zbigniew Wygoda, Jolanta Krajewska, E Gubała, Kornelia Hasse-Lazar and Michał Jarząb and has published in prestigious journals such as European Journal of Endocrinology, European Journal of Nuclear Medicine and Molecular Imaging and Endocrine Connections.

In The Last Decade

Zbigniew Puch

19 papers receiving 348 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zbigniew Puch Poland 9 335 179 79 50 38 20 362
Fernanda Bueno Argentina 11 315 0.9× 151 0.8× 46 0.6× 65 1.3× 27 0.7× 20 337
Erika Abelleira Argentina 11 322 1.0× 152 0.8× 43 0.5× 68 1.4× 27 0.7× 27 352
Leonardo D’Aloiso Italy 9 332 1.0× 229 1.3× 31 0.4× 58 1.2× 63 1.7× 12 385
Aleksandra Kropińska Poland 8 238 0.7× 133 0.7× 27 0.3× 47 0.9× 22 0.6× 14 270
André Borsatto Zanella Brazil 11 253 0.8× 149 0.8× 47 0.6× 39 0.8× 45 1.2× 24 280
Gabriela Franco Mourão Brazil 12 447 1.3× 296 1.7× 57 0.7× 40 0.8× 54 1.4× 36 466
Osamu Fukuoka Japan 8 219 0.7× 201 1.1× 43 0.5× 34 0.7× 32 0.8× 18 332
Donald R McClellan United States 8 357 1.1× 222 1.2× 16 0.2× 86 1.7× 34 0.9× 10 395
Aya Ebina Japan 9 438 1.3× 285 1.6× 44 0.6× 83 1.7× 35 0.9× 23 492
Simone M. Dustin United States 6 269 0.8× 188 1.1× 23 0.3× 50 1.0× 40 1.1× 8 323

Countries citing papers authored by Zbigniew Puch

Since Specialization
Citations

This map shows the geographic impact of Zbigniew Puch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zbigniew Puch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zbigniew Puch more than expected).

Fields of papers citing papers by Zbigniew Puch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zbigniew Puch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zbigniew Puch. The network helps show where Zbigniew Puch may publish in the future.

Co-authorship network of co-authors of Zbigniew Puch

This figure shows the co-authorship network connecting the top 25 collaborators of Zbigniew Puch. A scholar is included among the top collaborators of Zbigniew Puch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zbigniew Puch. Zbigniew Puch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kukulska, Aleksandra, Jolanta Krajewska, Zofia Kołosza, et al.. (2020). The role of postoperative adjuvant radiotherapy in local recurrence risk in medullary thyroid carcinoma. Endocrine Connections. 9(1). 1–8. 7 indexed citations
2.
Krajewska, Jolanta, Michał Jarząb, Aleksandra Kukulska, et al.. (2019). Postoperative Radioiodine Treatment within 9 Months from Diagnosis Significantly Reduces the Risk of Relapse in Low-Risk Differentiated Thyroid Carcinoma. Nuclear Medicine and Molecular Imaging. 53(5). 320–327. 12 indexed citations
3.
Kula, Dorota, Michał Kalemba, Zbigniew Puch, et al.. (2017). Wiek zachorowania i płeć jako czynniki modyfikujące związek polimorfizmów zlokalizowanych na chromosomie 9q22 i 14q13 z rakiem brodawkowatym tarczycy. Endokrynologia Polska. 68(3). 283–289. 3 indexed citations
4.
5.
Kukulska, Aleksandra, Jolanta Krajewska, Zofia Kołosza, et al.. (2016). The role of FDG-PET in localization of recurrent lesions of differentiated thyroid cancer (DTC) in patients with asymptomatic hyperthyroglobulinemia in a real clinical practice. European Journal of Endocrinology. 175(5). 379–385. 9 indexed citations
6.
Handkiewicz-Junak, Daria, Tomasz Gawlik, Zbigniew Puch, et al.. (2015). Recombinant human thyrotropin preparation for adjuvant radioiodine treatment in children and adolescents with differentiated thyroid cancer. European Journal of Endocrinology. 173(6). 873–881. 9 indexed citations
7.
Krajewska, Jolanta, Michał Jarząb, Agnieszka Czarniecka, et al.. (2015). Adjuvant radioiodine (RAI) treatment reduces the risk of relapse in low advanced differentiated thyroid carcinoma (DTC). Endocrine Abstracts.
8.
Kula, Dorota, Michał Kalemba, Beata Jurecka‐Lubieniecka, et al.. (2011). Genetic predisposition to papillary thyroid cancer.. PubMed. 61(5). 486–9. 6 indexed citations
9.
Kukulska, Aleksandra, Jolanta Krajewska, Zbigniew Puch, et al.. (2010). Radioiodine thyroid remnant ablation in patients with differentiated thyroid carcinoma (DTC): prospective comparison of long-term outcomes of treatment with 30, 60 and 100 mCi. Thyroid Research. 3(1). 9–9. 49 indexed citations
10.
Handkiewicz-Junak, Daria, Józef Roskosz, Kornelia Hasse-Lazar, et al.. (2009). 13-cis-retinoic acid re-differentiation therapy and recombinant human thyrotropin-aided radioiodine treatment of non-Functional metastatic thyroid cancer: a single-center, 53-patient phase 2 study. Thyroid Research. 2(1). 8–8. 38 indexed citations
11.
Krajewska, Jolanta, Agnieszka Czarniecka, Michał Jarząb, et al.. (2007). [Relapse of differentiated thyroid carcinoma in low-risk patients].. PubMed. 57(4). 386–91. 3 indexed citations
12.
Kukulska, Aleksandra, Jolanta Krajewska, Józef Roskosz, et al.. (2007). [Optimization of 131I ablation in patients with differentiated thyroid carcinoma: comparison of early outcomes of treatment with 100 mCi versus 60 mCi].. PubMed. 57(4). 374–9. 8 indexed citations
13.
Czarniecka, Agnieszka, Jan Włoch, Michał Jarząb, et al.. (2006). [Clinical course and treatment of patients with differentiated thyroid carcinoma diagnosed during the year 1995].. PubMed. 56(5). 758–65. 1 indexed citations
14.
Kołosza, Zofia, et al.. (2006). Risk of malignant tumors in first-degree relatives of patients with differentiated thyroid cancer -- a hospital based study.. PubMed. 53(1). 67–72. 4 indexed citations
15.
Jarząb, Barbara, Daria Handkiewicz-Junak, Józef Roskosz, et al.. (2003). Recombinant human TSH-aided radioiodine treatment of advanced differentiated thyroid carcinoma: a single-centre study of 54 patients. European Journal of Nuclear Medicine and Molecular Imaging. 30(8). 1077–1086. 51 indexed citations
16.
Handkiewicz-Junak, Daria, Józef Roskosz, Jan Włoch, et al.. (2001). Prognostic factors for differentiated thyroid carcinoma in young patients. Nowotwory Journal of Oncology. 51(4). 365–365. 3 indexed citations
17.
Roskosz, Józef, et al.. (2001). [Early evaluation of treatment effectiveness using 131I iodine radiotherapy in patients with differentiated thyroid cancer].. PubMed. 54 Suppl 1. 278–88. 15 indexed citations
18.
Jarząb, Barbara, Daria Handkiewicz-Junak, Jan Włoch, et al.. (2000). Multivariate analysis of prognostic factors for differentiated thyroid carcinoma in children. European Journal of Nuclear Medicine and Molecular Imaging. 27(7). 833–841. 120 indexed citations
19.
Jarząb, Barbara, Józef Roskosz, Daria Handkiewicz-Junak, et al.. (2000). Recombinant human TSH for the treatment of differentiated thyroid cancer metastatic to the spine.. PubMed. 3(2). 157–60. 5 indexed citations
20.
Puch, Zbigniew, et al.. (1999). [The usefulness of MIBI scintigraphy for postoperative monitoring of patients with thyroid cancer].. PubMed. 101(3). 227–32. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fernanda Bueno Breakdown of academic impact, for papers by Erika Abelleira Breakdown of academic impact, for papers by Leonardo D’Aloiso Breakdown of academic impact, for papers by Aleksandra Kropińska Breakdown of academic impact, for papers by André Borsatto Zanella Breakdown of academic impact, for papers by Gabriela Franco Mourão Breakdown of academic impact, for papers by Osamu Fukuoka Breakdown of academic impact, for papers by Donald R McClellan Breakdown of academic impact, for papers by Aya Ebina Breakdown of academic impact, for papers by Simone M. Dustin
Rankless by CCL
2026